Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

Cronos Group (NASDAQ:CRON) reported what executives described as a record year in 2025, with organic net revenue growth of 25 ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

About Cronos Group Inc. Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development.

For years, North American cannabis investors have endured a brutal hangover. Cronos Group (NASDAQ:CRON), once a darling of the 2018-2019 marijuana mania, watched its share price collapse more than 95% ...

Cronos Group’s smaller size and production capacity would be less of an issue if its market cap were not the third largest of firms listed in Figure 5. This lofty valuation makes it even harder for ...

Cronos Group Inc. (NASDAQ:CRON) is one of the Low Risk Penny Stocks to Buy Now. On February 26, Cronos Group Inc. (NASDAQ:CRON) reported its fiscal Q4 2025 earnings. The company posted $44.53 million ...

Cronos Group Inc. (NASDAQ:CRON) is one of the High Growth Penny Stocks That Are Profitable in 2025. On July 2, Cronos Group Inc. (NASDAQ:CRON) announced expanding its reach in Europe by forging a new ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Cronos Group is back in focus after analysts lifted their ...

Shares of Cronos Group Inc. CRON slipped 1.14% to $2.60 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.02% to ...

The Canadian cannabis purveyor saw a leap in revenue for its second quarter. This was largely, but not entirely, due to higher sales in its home market. For its second quarter, Cronos -- which reports ...